Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease (Q37825812)

23 August 2017

1 reference

title

Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

23 August 2017

0 references

0 references

1 reference

Anastassios C Manolakis

1

1 reference

23 August 2017

Andreas N Kapsoritakis

2

1 reference

23 August 2017

Elisavet K Tiaka

3

1 reference

23 August 2017

Spyros P Potamianos

4

1 reference

23 August 2017

4 January 2011

1 reference

Digestive Diseases and Sciences

23 August 2017

1 reference

23 August 2017

56

1 reference

23 August 2017

6

1 reference

23 August 2017

1601-1611

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-010-1494-9

23 August 2017

0 references

cites work

A soluble protein characteristic of the nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Calcium-dependent and -independent interactions of the S100 protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Intracellular and extracellular roles of S100 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

A review of the S100 proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

S100B in neuropathologic states: the CRP of the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

S100 proteins in the epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Multiple sclerosis cerebrospinal fluid biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

S100A5: a marker of recurrence in WHO grade I meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Identification of a novel, functional role for S100A13 in invasive lung cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

S100A13, a new marker of angiogenesis in human astrocytic gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

S100B testing in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Expression profile of the S100 gene family members in oral squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

S100 calgranulin proteins S100A8, S100A9 and S100A12 are expressed in the inflamed gastric mucosa of Helicobacter pylori-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Faecal calprotectin in colonic diverticular disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1494-9

Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease

21 January 2018

1 reference

12 December 2020

Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study

1 reference

12 December 2020

Accessory cells in Crohn's disease of the terminal ileum

1 reference

12 December 2020

The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn's disease: a comparison with ultrasound

1 reference

12 December 2020

Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis

1 reference

12 December 2020

Faecal calprotectin in children with chronic gastrointestinal symptoms

1 reference

12 December 2020

Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation

1 reference

12 December 2020

Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings

1 reference

12 December 2020

Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI

1 reference

12 December 2020

Assessment of ileal pouch inflammation by single-stool calprotectin assay

1 reference

12 December 2020

Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

1 reference

12 December 2020

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices

1 reference

12 December 2020

Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer

1 reference

12 December 2020

Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy

1 reference

12 December 2020

Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease

1 reference

12 December 2020

Expression of S100 protein family members in the pathogenesis of bladder tumors

1 reference

12 December 2020

In silico analysis and verification of S100 gene expression in gastric cancer

1 reference

12 December 2020

Endocrine tumors of the duodenum and upper jejunum. A study of 33 cases with clinico-pathological characteristics and hormone content

1 reference

12 December 2020

Fecal S100A12: a novel noninvasive marker in children with Crohn's disease

1 reference

12 December 2020

Enteric Glial-Derived S100B Protein Stimulates Nitric Oxide Production in Celiac Disease

1 reference

12 December 2020

Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy

1 reference

12 December 2020

Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival

1 reference

12 December 2020

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

1 reference

12 December 2020

Gene expression profiles of late colonic Crohn's disease.

1 reference

12 December 2020

Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease

1 reference

12 December 2020

Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease

1 reference

12 December 2020

Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease

1 reference

12 December 2020

Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease

1 reference

12 December 2020

The accessory cell populations in ulcerative colitis: a comparison between the colon and appendix in colitis and acute appendicitis

1 reference

12 December 2020

Differential expression of S100 gene family in human esophageal squamous cell carcinoma

1 reference

12 December 2020

Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes

1 reference

12 December 2020

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome

1 reference

12 December 2020

Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease

1 reference

12 December 2020

Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology

1 reference

12 December 2020

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

1 reference

12 December 2020

Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease

1 reference

12 December 2020

Can calprotectin predict relapse risk in inflammatory bowel disease?

1 reference

12 December 2020

Gastric cancers overexpress S100A calcium-binding proteins.

1 reference

12 December 2020

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease

1 reference

12 December 2020

10.1007/S10620-010-1494-9

Identifiers

DOI

1 reference

23 August 2017

1 reference